Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 247

1.

Prescription trends and the selection of initial oral antidiabetic agents for patients with newly diagnosed type 2 diabetes: a nationwide study.

Liu CH, Chen ST, Chang CH, Chuang LM, Lai MS.

Public Health. 2017 Jul 15;152:20-27. doi: 10.1016/j.puhe.2017.06.008. [Epub ahead of print]

PMID:
28719837
2.

Submicron-scale broadband polarization beam splitter using CMOS-compatible materials.

Lai MS, Huang CC.

Sci Rep. 2017 Jul 3;7(1):4531. doi: 10.1038/s41598-017-05019-3.

3.

Discretionary decisions and disparities in receiving drug-eluting stents under a universal healthcare system: A population-based study.

Kuo RN, Lai CL, Yeh YC, Lai MS.

PLoS One. 2017 Jun 8;12(6):e0179127. doi: 10.1371/journal.pone.0179127. eCollection 2017.

4.

Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study.

Lu LC, Chen PJ, Yeh YC, Hsu CH, Chen HM, Lai MS, Shao YY, Cheng AL.

Anticancer Res. 2017 May;37(5):2593-2599.

PMID:
28476832
5.

Adult mortality of diseases and injuries attributable to selected metabolic, lifestyle, environmental, and infectious risk factors in Taiwan: a comparative risk assessment.

Lo WC, Ku CC, Chiou ST, Chan CC, Chen CL, Lai MS, Lin HH.

Popul Health Metr. 2017 May 3;15:17. doi: 10.1186/s12963-017-0134-4. eCollection 2017.

6.

Adult mortality of diseases and injuries attributable to selected metabolic, lifestyle, environmental, and infectious risk factors in Taiwan: a comparative risk assessment.

Lo WC, Ku CC, Chiou ST, Chan CC, Chen CL, Lai MS, Lin HH.

Popul Health Metr. 2017 May 3;15(1):17. doi: 10.1186/s12963-017-0134-4.

7.

National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients.

Shao YY, Hsiue EH, Hsu CH, Yao CA, Chen HM, Lai MS, Cheng AL.

Oncologist. 2017 Jul;22(7):843-849. doi: 10.1634/theoncologist.2016-0367. Epub 2017 Apr 13.

PMID:
28408618
8.

Impact of hospitalization on medication adherence estimation in claims data.

Dong YH, Choudhry NK, Krumme A, Lee MP, Wu LC, Lai MS, Gagne JJ.

J Clin Pharm Ther. 2017 Jun;42(3):318-328. doi: 10.1111/jcpt.12517. Epub 2017 Mar 29.

PMID:
28370404
9.

Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.

Dong YH, Alcusky M, Maio V, Liu J, Liu M, Wu LC, Chang CH, Lai MS, Gagne JJ.

BMJ Open. 2017 Mar 31;7(3):e012997. doi: 10.1136/bmjopen-2016-012997.

10.

Long-term Surveillance Following Intralesional Steroid Injection for Benign Vocal Fold Lesions.

Wang CT, Lai MS, Cheng PW.

JAMA Otolaryngol Head Neck Surg. 2017 Jun 1;143(6):589-594. doi: 10.1001/jamaoto.2016.4418.

PMID:
28334309
11.

All-Cause and Cause-Specific Mortality in Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study.

Lee MS, Yeh YC, Chang YT, Lai MS.

J Invest Dermatol. 2017 Jul;137(7):1468-1473. doi: 10.1016/j.jid.2017.01.036. Epub 2017 Feb 28.

PMID:
28257796
12.

Are hospital cancer caseloads related to the validity of staging data reported? A lesson from National Cancer Registry in Taiwan.

Cheng CY, Chiang CJ, Hsiao JK, Lai MS.

Jpn J Clin Oncol. 2017 Jan;47(1):18-24. doi: 10.1093/jjco/hyw149. Epub 2016 Oct 7.

PMID:
28122891
13.
14.

Real-life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong.

Chan HL, Tsang OT, Hui YT, Fung J, Lui GC, Lai CL, Wong GL, Chan KH, But DY, Lai MS, Lao WC, Chan CK, Lam YS, Seto WK, Li C, Yuen MF, Wong VW.

J Gastroenterol Hepatol. 2017 Jun;32(6):1230-1233. doi: 10.1111/jgh.13663.

PMID:
27869328
15.
16.

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice.

Liang YH, Shao YY, Liao BC, Lee HS, Yang JC, Chen HM, Chiang CJ, Cheng AL, Lai MS.

J Cancer. 2016 Jul 7;7(11):1515-23. doi: 10.7150/jca.15180. eCollection 2016.

17.

Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.

Dong YH, Chang CH, Wu LC, Lai MS.

Eur J Clin Pharmacol. 2016 Oct;72(10):1265-1273. doi: 10.1007/s00228-016-2097-y. Epub 2016 Jul 22.

PMID:
27444174
18.

No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan.

Chang CH, Chang YC, Lin JW, Caffrey JL, Wu LC, Lai MS, Chuang LM.

Int J Cardiol. 2016 Oct 1;220:14-20. doi: 10.1016/j.ijcard.2016.06.125. Epub 2016 Jun 24.

PMID:
27389437
19.

Key opioid prescription concerns in cancer patients: A nationwide study.

Lin CP, Hsu CH, Fu WM, Chen HM, Lee YH, Lai MS, Shao YY.

Acta Anaesthesiol Taiwan. 2016 Jun;54(2):51-6. doi: 10.1016/j.aat.2016.05.002. Epub 2016 Jun 15.

20.

Supplemental Content

Support Center